Munich startup dehaze targets earlier detection
Author: Michael
Deal unites clinical diagnostic powerhouse with
Alterity Therapeutics received positive regulator
Aspen presented 12-month data from the first eigh
Voyager will present eight oral and poster presen
Annovis has published peer-reviewed Phase 2/3 res
New funding and partnerships position Endlyz to
Collaboration signals rising confidence in gene
Smart Nanovirus debuts RIGVIR X, a monthly liqui
New trial data point to longer-lasting mobility